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The pleckstrin homology domain of oxysterol-binding protein
recognises a determinant specific to Golgi membranes
Timothy P. Levine and Sean Munro
Background: Peripheral membrane proteins are targeted to the cytoplasmic
face of specific intracellular membranes. The organelle-specific ligands
recognised by peripheral proteins include both other proteins and lipids.
Oxysterol-binding protein (OSBP) translocates from the cytoplasm to the Golgi
apparatus on binding oxygenated derivatives of cholesterol. The mechanism by
which OSBP recognises the Golgi is unknown. It does, however, contain a
pleckstrin homology (PH) domain, which in other proteins has been found to
mediate regulated membrane binding, although in all previously studied
examples the binding is to the plasma membrane.
Results: The PH domains of OSBP and of a yeast homologue, Osh1p, were
sufficient to target fusion proteins specifically to mammalian Golgi membranes.
In addition, high level expression disrupted Golgi architecture and prevented
forward traffic of cargo protein. In vitro, the OSBP PH domain bound to Golgi
membranes in a manner apparently dependent on phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2) or a related phosphatidylinositide. The OSBP PH
domain bound to PI(4,5)P2 in liposomes with a submicromolar dissociation
constant. 
Conclusions: The PH domains of OSBP and its yeast homologue recognise a
determinant which is specific to Golgi membranes and important for Golgi
function. The determinant appears to be a combination of a phosphatidylinositol
polyphosphate and a second, Golgi-specific feature.
Background
Many peripheral membrane proteins found on the cyto-
plasmic face of intracellular membranes have a distribution
restricted to a specific organelle. The mechanisms underly-
ing this specificity are largely unknown. Some peripheral
proteins interact directly with the cytoplasmic domains of
integral membrane proteins, the targeting of which is much
better understood. Proteins containing Src homology 2
(SH2) or SH3 domains, for example, interact with specific
membrane proteins via recognition of phosphotyrosine or
proline-containing motifs. Other peripheral proteins appar-
ently recognise a more general feature of the lipid bilayer,
however, such as a membrane-specific lipid. Proteins with a
high affinity for phosphatidylinositol 3,4,5-trisphosphate
(PI(3,4,5)P3), for example, are believed to be targeted to
the plasma membrane as a result of receptor-mediated pro-
duction of this lipid [1,2]. Specific targeting of peripheral
membrane proteins to internal organelles is less well under-
stood than targeting to the plasma membrane and no
general feature specific to the lipid bilayer of an internal
organelle has, as yet, been identified [3]. 
Oxysterol-binding protein (OSBP) provides an interesting
example of a peripheral protein for which it might be pos-
sible to identify the organelle-specific ligand responsible
for its localisation. OSBP was originally identified as the
major binding activity for oxysterols in mammalian cytosol
[4,5]. Oxysterols are oxygenated by-products of choles-
terol which are made in mitochondria at low concentra-
tions and are potent down-regulators of intracellular
cholesterol levels [6–8]. OSBP is normally distributed
throughout the cytoplasm, but when oxysterols are added
to cells it translocates to the Golgi apparatus [9]. Although
the precise function of OSBP is unknown, overexpression
of OSBP alters cholesterol regulation [10], and disruption
of the Golgi apparatus reduces the action of oxysterols on
cholesterol synthesis [11]. It is possible, therefore, that
oxysterol-dependent translocation of OSBP to the Golgi
might affect cholesterol homeostasis. The mechanism for
this could involve, for example, either the traffic of choles-
terol-rich lipid microdomains [12,13] or the activation of
transcription factor precursors resident in the endoplasmic
reticulum (ER), which regulate sterol metabolism [14]. 
Analyses of deletion mutants of OSBP revealed that the
carboxy-terminal half of the protein binds oxysterols, and
that when this is removed the remainder of the protein
localises to the Golgi in the presence or absence of oxys-
terols [9]. Subsequently, OSBP has been shown to contain a
pleckstrin homology (PH) domain near its amino terminus
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[15]. A PH domain is also found in three homologues of
OSBP in the budding yeast Saccharomyces cerevisiae, of
which Osh1p is the most similar to OSBP (Figure 1). 
PH domains are sequences of approximately 100 amino
acids sharing some primary sequence and a lot of secondary
and tertiary structure [15,16]. Many proteins containing PH
domains translocate to the cytoplasmic face of the plasma
membrane to exert their actions, such as kinases (e.g. PKB
and Btk), adaptor proteins (e.g. IRS-1 and Grb10), and reg-
ulators of small GTPases (e.g. Ras-GAP and SOS) [17]. In
several cases, the PH domain has been shown to be
required for translocation to the plasma membrane, and for
some of these proteins, the PH domain can be functionally
replaced by a membrane anchor such as a palmitoylation
motif [17]. All previous studies of targeting by isolated PH
domains have investigated domains which localise to the
plasma membrane. However, a number of proteins with
PH domains are localised to other compartments, including
to the Golgi apparatus. In this study, we have investigated
membrane targeting by the PH domain of OSBP. This
domain was shown to be sufficient for Golgi-specific 
targeting of a reporter peripheral protein. This is the first
case of a PH domain mediating specific targeting to an
intracellular organelle. The ability to recognise the Golgi
was also shown by the PH domain of Osh1p, but not by
other PH domains. High level expression of the PH
domain of OSBP markedly disrupted Golgi structure and
blocked the exocytic pathway. These results suggest that
the ligand for the PH domain of OSBP is evolutionarily
conserved and important for Golgi function. In addition,
we have identified a role for phosphatidylinositol-4,5-bis-
phosphate (PI(4,5)P2), or a closely related phosphatidyli-
nositide, in this localisation. Given that these
phospholipids are not uniquely restricted to Golgi mem-
branes, our results imply that localisation requires a second,
Golgi-specific feature.
Results
Golgi targeting by the PH domain of OSBP
To examine the role of the PH domain of OSBP (OSBP
PH) in targeting to the Golgi apparatus, COS cells were
transfected with a plasmid expressing green fluorescent
protein (GFP) fused to OSBP PH. As a control, cells were
also transfected with a plasmid expressing GFP fused to a
different PH domain, that of β1Σ2 spectrin. Twenty four
hours after transfection, the intracellular distribution of
the GFP chimeras was examined by fluorescence
microscopy of live cells. The OSBP PH–GFP fusion
protein was concentrated in brightly fluorescent perinu-
clear ribbons, characteristic of the Golgi apparatus
(Figure 2a). In contrast, cells expressing the spectrin
PH–GFP fusion protein showed diffuse cytoplasmic fluo-
rescence with no concentration in any part of the cell. We
also examined the intracellular localisation of GFP
fusions with PH domains from two other proteins, phos-
pholipase C δ1 (PLCδ1) and ARNO, a recently described
ADP-ribosylation factor GDP/GTP exchange factor [18].
Both showed a diffuse distribution throughout the cell
similar to that seen with the spectrin PH domain
(Figure 2a and data not shown). To confirm that the
Golgi was the organelle bound by the OSBP PH domain,
cells were fixed and permeabilised and OSBP PH–GFP
was found to colocalise almost entirely with β′-COP and
TGN46, markers of the cis/medial-Golgi and the trans-
Golgi network, respectively (Figure 2c and data not
shown) [19,20]. Immuno-electron microscopy of cryosec-
tions of transfected cells showed that the fusion protein
was concentrated on one side of the Golgi stack and in an
adjoining reticular tubular network that could also be
labelled with antibodies to the TGN46 marker
(Figure 2b). In addition, in some higher expressing cells,
staining could be seen to extend further into the stack
(data not shown).
We were able to exclude various trivial explanations for
this distinctive behaviour of the OSBP PH domain.
Firstly, analysis of expressed proteins by western blotting
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Figure 1
Structures of intact OSBP and GFP–PH domain fusion proteins.
(a) Mammalian OSBP contains two readily identifiable structures: a
PH domain (residues 87–185) and a domain (residues 417–750) that
binds to oxygenated sterols, which is present in all other OSBP
homologues [9]. S. cerevisiae has seven genes encoding homologues
to OSBP. Three contain PH domains, of which Osh1p is the most
similar to OSBP (26% identity). Osh1p also contains two ankyrin
repeats. (b) Structure of the GFP fusion proteins containing the PH
domain from OSBP or Osh1p. Further PH domains were also
expressed fused to GFP in a similar way.
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showed that the different PH domain fusion proteins all
accumulated as intact GFP-tagged molecules, indicating
that the diffuse distribution does not reflect degradation
of the PH domain (data not shown). Secondly, Golgi
localisation does not require the presence of GFP, as
similar results were seen in fixed cells expressing OSBP
PH tagged with Myc and influenza virus hemagglutinin
epitope tags (data not shown). Taken together, these
results demonstrate that OSBP PH is sufficient to target
a heterologous protein to the Golgi apparatus. This is the
first example of a PH domain which has been shown to
localise specifically to a membrane other than the plasma
membrane [17].
The capacity of PH domains to recognise the Golgi is
evolutionarily conserved
We next investigated whether any other PH domains had
the ability to recognise a feature on the Golgi apparatus.
Two other proteins containing PH domains have been
previously proposed to be localised to the Golgi, protein
kinase C-µ (PKCµ) and phosphoinositol 4-kinase-α
(PI4Kα) [21,22]. The PH domains from these proteins
were also expressed in COS cells but showed no specific
membrane localisation (data not shown). We also studied
the PH domain from one of OSBP’s full-length homo-
logues in S. cerevisiae, Osh1p (Figure 1). The intracellular
location, and indeed function, of this protein is
unknown, but like OSBP it contains a PH domain in its
amino-terminal portion [23,24]. Moreover, the PH
domain is the best conserved portion of the sequence
outside of the carboxy-terminal oxysterol-binding
domain, having 67% similarity (36% identity) with that of
OSBP. When this domain was expressed in COS cells as
a fusion to GFP, it was also localised to Golgi membranes
(Figure 2a). GFP fusions to three other PH domains from
yeast proteins, Num1p, Stt4p and Cdc24p, gave a diffuse
distribution (data not shown). Thus, whilst a PH domain
may not be the sole targeting determinant in all Golgi
proteins that contain one, the PH domain of OSBP is
able to recognise a specific feature on the cytoplasmic
face of the Golgi in a manner highly conserved through
eukaryotic evolution.
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OSBP PH localises to the Golgi apparatus in COS cells. (a) Confocal
images of live COS cells transfected 24 h previously with plasmids
expressing fusion proteins of GFP with the PH domains of OSBP,
β1Σ2 spectrin, ARNO and Osh1p. (b) Double-label immuno-electron
microscopy of a cryosection of COS cells expressing OSBP PH–GFP
fusion protein (GFP 10 nM gold, TGN46 5 nM gold). Scalebar is
200 nM. (c) Confocal immunofluorescent images of COS cells
expressing the OSBP PH–GFP fusion protein, and then fixed 24 h
post-transfection, permeabilised and stained for β′-COP. In the bottom
panels, BFA was added 2 min prior to fixation, and the same exposure
was used for the two sets of cells. (d) As in (a), except the PH domain
is either wild-type OSBP or a mutant with arginines 107 and 108
mutated to glutamate (OSBP–RR→EE). The right-hand cell illustrates
the faint Golgi staining visible in some cells.
Recognition of the Golgi by the OSBP PH domain is
inhibited by Brefeldin A 
The nature of the feature on the Golgi recognised by the
OSBP PH domain was investigated by treating cells with
Brefeldin A (BFA), a drug that causes a rapid loss of coat
components and peripheral proteins from Golgi mem-
branes, followed by a retrograde traffic of Golgi membrane
proteins to the ER [25]. Treatment of COS cells with BFA
led to a rapid dissociation of OSBP PH–GFP from Golgi
membranes, with most of the protein having dissociated
within 2 minutes (Figure 2c). Consistent with previous
studies [25], immunofluorescence confirmed that after this
short BFA treatment coat proteins were fully dissociated
(Figure 2c), but Golgi-resident membrane proteins such as
TGN46 and galactosyltransferase had not yet redistributed
to the ER (data not shown). This suggests that the localisa-
tion of OSBP PH is not simply the result of tight binding
to an integral membrane protein of the Golgi. 
The effect of high levels of expression of OSBP PH on the
Golgi apparatus
OSBP is known to translocate to the Golgi only in
response to exogenous signals [9]. This raises the issue of
whether the feature recognised by the PH domain exists
solely to provide a target for this translocation, or whether
it is also recognised by other peripheral proteins of the
Golgi. Some indication that the latter is the case is pro-
vided by the effect of expressing the OSBP PH domain at
high levels. The distribution of the PH–GFP fusion
protein shown in Figure 2 is that seen in cells 24–30 hours
post-transfection. Most of the GFP is localised to the
Golgi, with small amounts also present in the nucleus and
cytosol. At higher expression levels obtained with stronger
promoters and at longer times after transfection, however,
OSBP PH fusion protein could be seen to be accumulat-
ing throughout the cell (Figure 3a). In these higher
expressing cells, not only was the protein mostly dis-
persed, but the residual Golgi-localised protein was no
longer in a clearly connected structure, but instead was
either vesiculated or absent, suggesting that the Golgi was
disrupted in some way. Analysis of cellular proteins by
protein blotting showed that the expressed OSBP PH
remained intact (data not shown), and the effect was seen
irrespective of whether the PH domain was tagged with
GFP or a peptide, or whether the OSBP or the yeast
Osh1p PH domain was used (Figure 3a).
Figure 3a shows that the localisation of some endogenous
Golgi proteins was also strikingly disturbed in the overex-
pressing cells. Firstly, the membrane protein TGN46 was
either dispersed or apparently absent in the highest express-
ing cells. A similar result was seen with galactosyltransferase
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Figure 3
Overexpression of OSBP PH disperses Golgi
proteins. (a) Confocal images of COS cells
transfected 48 h previously and expressing
high levels of the indicated PH domains
tagged with GFP. Cells were also labelled
with antibodies to TGN46. Untransfected
cells are also visible, showing normal Golgi
protein localisation. The first row shows a cell
with high expression of OSBP PH–GFP, the
second row shows a cell with intermediate
expression illustrating the vesiculated
distribution of TGN46. (b) As in (a), except
that the OSBP PH domain was tagged with
either GFP or the HA epitope and the cells
were co-labelled with other compartmental
markers, as indicated. Note that the GFP-
tagged PH domains show some accumulation
in the nucleus. The reason for this is unclear,
but may reflect the presence of a weak
nuclear localisation signal in GFP.
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(data not shown). Secondly, γ-adaptin, a component of the
peripherally associated Golgi-specific AP1 coat, was com-
pletely redistributed to the cytoplasm (Figure 3b) and a
similar result was seen with the Golgi-specific AP3 adaptin,
and with Golgi-associated clathrin, but not with plasma-
membrane-associated clathrin (data not shown). As the tran-
siently transfected cells are only a fraction of the population,
it was not possible to determine whether the dispersed pro-
teins are degraded. This seems unlikely though, at least ini-
tially. γ-Adaptin is clearly visible dispersed in the cytoplasm
(Figure 3b), and for the membrane proteins the cells with
intermediate levels of expression showed many small scat-
tered structures (Figure 3a, second row), suggesting that the
initial fate is membrane vesiculation with the ultimate lack
of staining possibly reflecting the dispersal of small vesicles
throughout the COS cell cytoplasm. There was no evidence
of the Golgi proteins returning to the ER.
These effects on the Golgi markers were seen with both
the OSBP and Osh1p PH domains, but were not seen with
any other PH domain. This is illustrated in Figure 3a with
the spectrin PH domain and TGN46, but no effect on any
Golgi marker examined was seen in cells expressing the
spectrin, PLCδ1 or ARNO PH domains, even at the
highest levels (data not shown). These effects of OSBP
PH were not restricted to COS cells, as dispersal of
peripheral proteins and loss of Golgi residents were also
seen in transfected NRK cells (data not shown). In addi-
tion, overexpression of the OSBP and Osh1p PH domains,
or indeed the spectrin, PLCδ1 and ARNO PH domains,
did not have any discernible effect on other organelles
such as the ER or lysosomes (Figure 3b). Interestingly,
proteins of the cis side of the Golgi, such as syntaxin 5 or
β′-COP, were less markedly affected, with only partial dis-
ruption in the highest expressing cells (Figure 3b and data
not shown). These results suggest that a saturating level of
the Golgi-targeted PH domains specifically disrupts the
Golgi apparatus. 
Overexpression of the OSBP PH domain blocks exocytic
traffic
The severe perturbation of the Golgi apparatus induced
by high levels of the OSBP PH domain might be
expected to interfere with the exocytic pathway. To
investigate this, epitope-tagged PH domains were co-
expressed with a version of the ts045 mutant of vesicular
stomatitis virus (VSV) G protein fused to GFP [26]. In
cells maintained at 39.5°C, this mutant protein cannot
fold and accumulates in the ER. Upon cooling to the per-
missive temperature of 31°C, however, the protein folds
and traffics from the ER to the cell surface. Figure 4
shows this process in cells overexpressing the spectrin PH
domain, where traffic is apparently unaffected and the
protein is mostly at the plasma membrane after 2 hours. In
cells expressing high levels of the OSBP PH domain, the
VSV G protein is still able to exit the ER and accumulates
in a perinuclear region, indicating that protein export from
the ER is still functional. Progress beyond this point is
blocked, however, with bright Golgi staining still visible
even after 2 hours, a time when no such localisation is
seen in cells expressing the VSV G protein alone, or with
the spectrin PH domain. 
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Figure 4
Overexpression of OSBP PH blocks export of
VSV G protein from the Golgi apparatus.
Confocal images of COS cells co-transfected
with plasmids expressing the ts045 mutant of
VSV G protein tagged with GFP (VSVG–GFP
[26]), and the indicated PH domains tagged
with the HA epitope. After culturing at 39.5°C
for 30 h post-transfection, cells were fixed or
incubated for the indicated times at 31°C
prior to fixation and the HA-tagged PH domain
localised by immunofluorescence. 
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The fact that the VSV G protein is able to accumulate in a
post-ER structure in cells overexpressing the OSBP PH
domain suggests that a residual cis-like Golgi structure is
still present, consistent with the lack of complete disper-
sal of cis markers such as COP I. Overall, these results
indicate that overexpression of the OSBP PH domain
does not prevent transport from ER to cis Golgi, but that
there is no transport beyond this point as the latter parts
of the Golgi are dispersed. This suggests that saturation of
the Golgi binding sites for the OSBP interferes with the
action of a protein or proteins required for normal Golgi
structure or function.
Binding of the OSBP PH domain to purified Golgi
membranes
To further investigate the binding of OSBP PH to Golgi
membranes, we developed two in vitro assays. In the first
of these, semi-permeabilised NRK cells were incubated
with purified recombinant PH–GFP fusion proteins and,
in the presence of an ATP-regenerating system, OSBP
PH–GFP was found to be colocalised with TGN38 and γ-
adaptin (data not shown). As a more quantitative approach
to study the Golgi binding, bacterially expressed OSBP
PH–GFP was incubated with purified rat liver Golgi mem-
branes. Membranes were then pelleted, and the bound PH
domain quantified by either fluorimetry or protein blotting
(Figure 5a). The binding of up to 20% of added OSBP
PH–GFP was detected, which was inhibited more than
90% by the addition of excess OSBP PH without GFP and
was also not seen with other membranes, such as mito-
chondria. The PH domains of spectrin, PLCδ1 and
ARNO, also expressed fused to GFP, all showed little
membrane binding. Thus, the in vitro assay recreates the
membrane specificity of PH domains seen both in whole
cells and in semi-permeabilised cells. In vitro binding of
the OSBP PH domain required ATP, as binding without
ATP was inhibited by 75%. Binding did not need cytosol,
rather cytosols derived from pig brain or rat liver inhibited
binding by approximately 50% (data not shown). These
results imply that binding of OSBP PH requires an ATP-
dependent activity present on Golgi membranes. Inclusion
of [γ32P]ATP in these incubations revealed that OSBP PH
was not phosphorylated during in vitro binding (data not
shown). Salt-washing or pre-treatment of membranes with
trypsin or chymotrypsin (3 mg/ml, 30 minutes, 0°C, which
is sufficient to remove all detectable syntaxin 5) did not
affect binding of OSBP PH.
Several PH domains have previously been shown to bind
PI(4,5)P2 [17,27]. When Golgi membranes were pre-incu-
bated with bacterially expressed PLCδ1, which removes
the head-group from PI(4,5)P2, there was a 90% inhibition
in binding of OSBP PH (Figure 5b). This effect was not
the result of competition between OSBP PH and the PH
domain of PLCδ1, as the inhibition required 10 µM free
calcium, which is an essential co-factor for catalysis by
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Figure 5
OSBP PH binding to rat liver Golgi membranes identifies high-affinity
binding mediated by PI(4,5)P2 or PI(4)P. (a) Rat liver Golgi
membranes bind OSBP PH in an ATP-dependent manner. Fusion
proteins of GFP with the PH domain from OSBP, spectrin, PLCδ1 or
ARNO were incubated with purified membranes — Golgi or
mitochondria (mito) — with or without ATP and an excess of
nonfluorescent competitor OSBP PH, as indicated. (b) OSBP
PH–GFP binding to Golgi membranes is inhibited by removal of
PI(4,5)P2. Incubations of OSBP PH, Golgi membranes and ATP were
supplemented with purified PLCδ1, full length or without its PH domain
(deletion of residues 1–132), either with or without 10 µM free
calcium, as indicated. (c) Binding of OSBP PH to Golgi membranes is
saturable. OSBP PH was added as indicated to binding reactions
containing OSBP PH–GFP, Golgi membranes and ATP. Membrane-
bound OSBP PH–GFP fusion protein was isolated by pelleting
through a cushion, and quantified both by fluorimetry (histograms,
showing means of three determinations with error bars for standard
deviations) and protein blotting. Blots were probed with antibodies to
the Golgi resident syntaxin 5 to confirm uniform recovery of
membranes (shown for (c) only). 
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PLCδ1, but is not involved in binding by its PH domain
[28]. Additionally, an amino-terminally deleted form of
PLCδ1 missing the PH domain inhibited 80% of OSBP
PH binding and also required calcium for inhibition. The
reduction in inhibitory effect caused by amino-terminal
deletion of PLCδ1 may result from the inability of PLCδ1
to carry out processive catalysis in the absence of its PH
domain [28]. Since PLCδ1 cannot accommodate 3-phos-
phorylated inositides in its active site, these results
suggest that the binding of OSBP PH is dependent on
PI(4,5)P2, or phosphatidylinositol-4-phosphate (PI(4)P), or
possibly the newly identified PI(5)P [29,30]. 
For several PH domains it has been shown that the PIP
phosphates are bound by conserved basic residues. The
OSBP PH domain has several of these residues, including
a highly conserved arginine (residue 108) which is con-
served in many PH domains and has been shown in
several cases to be essential for PIP binding [31,32]. A
mutant form of the OSBP PH–GFP fusion protein in
which this arginine 108 and the adjacent arginine 107 were
altered to glutamate (OSBP–RR→EE) was expressed in
COS cells. The mutant protein accumulated to similar
levels to the wild-type protein but showed a diffuse distri-
bution, although some faint Golgi staining was still visible
in some cells (Figure 2d).
Quantitation of binding to Golgi membranes and
liposomes
The affinity of OSBP PH for purified Golgi membranes
was determined by using fluorimetry to quantify the
amount of OSBP PH–GFP bound in the presence of
increasing amounts of untagged OSBP PH (Figure 5c).
Scatchard analysis indicated a dissociation constant of
1.9 µM (± 0.4, n = 3) and a number of binding sites of 2.7
nanomoles per mg Golgi protein (± 0.3, n = 3). If these
binding sites consist of a protein receptor, then assuming
a 1:1 stochiometry and a molecular weight of 60,000 kDa,
the OSBP PH receptor would make up approximately
18% by weight of Golgi protein, which seems unlikely.
Binding to a phospholipid species such as a PIP,
however, would better explain this result. It has been
estimated that the ratio by weight of membrane protein
to phospholipid is 3:2 [33], 10% of which is PI [34].
Hence, there are approximately 70 nanomoles of PI per
mg Golgi protein, and so 1:1 binding of OSBP PH to a
PIP could be accounted for if only 4% of Golgi PI were
correctly phosphorylated to make an appropriate binding
site. Therefore, the number of binding sites for OSBP
PH in this in vitro assay suggests that OSBP PH binds to
a minor Golgi phospholipid species, such as PI(4,5)P2,
the level of which in whole cells is 2–4 PI(4,5)P2 per 100
PI molecules [35]. 
The affinity of OSBP PH for purified PI(4,5)P2 and PI(4)P
was examined by isothermal microcalorimetry, using 
liposomes containing 5% PIP and 95% dimyristoylphos-
phatidylcholine (DMPC). Analysis of data from three sepa-
rate experiments showed that the proportion of PI(4,5)P2
molecules available for binding was 53% (± 7%), compati-
ble with the lipid being distributed equally between both
sides of the liposome bilayer. No binding was detected
between OSBP PH and liposomes containing PI, and the
Kd values obtained for PI(4,5)P2 and PI(4)P were 0.34 µM
(± 0.11) and 0.71 µM (± 0.36), respectively. This is a higher
affinity than seen with other PH domains binding to
PI(4,5)P2, such those of PLCδ1 and SOS [36,37]. 
In contrast, OSBP PH showed no reaction in calorimetric
titrations with either IP3 or glycero-PI(4,5)P2, suggesting a
low affinity of OSBP PH for molecules containing the
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Figure 6
OSBP PH does not bind IP3. BIAcore measurements of liposomes
containing PI(4,5)P2 (final concentration 1 µM) binding simultaneously
to three different PH domains (a) in buffer alone or (b) in the presence
of 2.5 mM IP3. At t = 0, liposomes (mixed phospholipids containing
PI(4,5)P2, 1 µM final concentration) were injected for 3 min over
immobilised OSBP PH, the PH domain of β1Σ2 spectrin (both as fusion
proteins with GFP) and full-length PLCδ1, as indicated. In (b), 2.5 mM
IP3 was added for 3 min before liposomes, and during the injection of
liposomes, which was followed by buffer only, accounting for the sharp
vertical rise and fall in sensorgrams at –180 sec and +180 sec,
respectively. Liposomes without PI(4,5)P2 showed no binding. 
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head-group of PI(4,5)P2 in the absence of a lipid environ-
ment (data not shown). This result was confirmed by com-
petition studies between IP3 and PI(4,5)P2 using surface
plasmon resonance to follow binding of liposomes to
immobilised PH domains (Figure 6). Simultaneous
binding of liposomes to three different PH domains
showed that, as expected, both OSBP PH and full-length
PLCδ1, but not the PH domain of β1Σ2 spectrin, bound to
liposomes containing PI(4,5)P2 (final concentration 1 µM,
Figure 6a). IP3 at 2.5 mM failed to compete with the
binding by these liposomes to OSBP PH (Figure 6b). In
contrast, the binding of the same liposomes to full-length
PLCδ1 was entirely inhibited by excess IP3, as expected
from previous work [38]. Thus, the affinity of OSBP PH
for IP3 is at least 100-fold less than that for PI(4,5)P2. 
Discussion 
Previous studies have identified a role for PH domains in
membrane targeting of proteins localised to the plasma
membrane [27,39,40]. OSBP’s localisation to the Golgi
apparatus [9] led us to investigate whether a PH domain
could be responsible for targeting to a membrane other
than the plasma membrane. 
The results of in vivo expression studies and in vitro
binding assays show that the PH domain of OSBP is suffi-
cient for Golgi targeting. This targeting was also shown by
the PH domain of Osh1p, a yeast homologue of OSBP, but
was not seen with any of the PH domains of other proteins
tested, including those of other Golgi-localised proteins,
and has not been seen in any previous study on PH domain
localisation [17]. These results suggests that a determinant
on the cytoplasmic face of Golgi membranes is specifically
recognised by the PH domains of both OSBP and Osh1p,
implying a high degree of conservation of the determinant
in eukaryotes. In addition, it has recently been reported
that deletion of the PH domain in OSBP results in a loss of
both its ability to bind the Golgi and its function in choles-
terol homeostasis [10]. Although this deletion could have
affected the folding of the rest of the protein, it is at least
consistent with the PH domain being necessary for Golgi
targeting, as well as being sufficient. 
A more general role for the Golgi determinant recognised
by the PH domain of OSBP is suggested by the observa-
tion that high-level expression leads to the dispersal of
peripheral and membrane proteins of the Golgi and dis-
ruption of exocytic traffic. The trans-Golgi is particularly
affected, with complete dispersal of TGN46 and γ-
adaptin, whilst newly assembled VSV G trimers still reach
a post-ER compartment and COP I remains partially
localised. It is not clear how the Golgi membrane proteins
are dispersed. It appears that they enter small vesicles,
either by specific budding or by less physiological frag-
mentation of membranes, and that these vesicles are then
unable to fuse with any organelle. It should be stressed
that the normal function of OSBP is unlikely to be to
mediate the dispersal of the Golgi in response to oxys-
terols. Treatment of cells with 25-hydroxycholesterol does
not lead to obvious disruption of the Golgi, and indeed
OSBP in normal cells is present at levels so low that they
preclude detection by immunofluorescence [9]. Rather it
seems more likely that when OSBP performs its role in
the presence of oxysterols it targets to the Golgi by recog-
nising a binding site shared by other peripheral proteins,
and that artificially increasing the level of OSBP PH
titrates out these sites.
If there is a specific determinant that is recognised by
OSBP and other Golgi proteins, the next issue is the
nature of this determinant. Many PH domains bind
PI(4,5)P2 [17,27], but in some cases this binding is weak
[17,38], and it has been suggested that in these cases the
physiological ligand may instead be an unknown phos-
pholipid or possibly a phosphoprotein [39]. For OSBP
PH, however, isothermal calorimetric measurement
showed high-affinity binding to PI(4,5)P2 and PI(4)P (Kd
0.34 µM and 0.71 µM, respectively). Further evidence
that OSBP PH localisation is mediated by a PIP comes
from the inhibition of OSBP PH binding following treat-
ment of Golgi membranes in vitro by PLCδ1. OSBP PH
has been recently shown to bind a broad range of PIPs
with similar affinity, including PI(4,5)P2, PI(3,4)P2 and
PI(3,4,5)P3 [41]. However, there are two lines of evidence
against a role for 3-phosphorylated PIPs in localising
OSBP PH to the Golgi. Firstly, PLCδ1 cleaves off PIP
head-groups with a substrate preference
PI(4,5)P2 > PI(4)P >> PI, but cannot accommodate 3-
phosphorylated PIPs in its catalytic site [29]. Secondly,
targeting of OSBP PH to Golgi membranes in both COS
cells and a semipermeable cell system was resistant to
wortmannin at concentrations high enough (1 µM and
2 µM, respectively, data not shown) to significantly
inhibit even the most wortmannin-resistant phospho-
inositide 3-kinases currently known [42]. Hence, the can-
didate molecules for mediating OSBP PH targeting are
PI(4,5)P2, PI(4)P or the recently identified PI(5)P [30]. 
Despite being implicated as binding partners for Golgi-
localised OSBP PH, PI(4,5)P2 and closely related PIPs
are found in other organelles, including the plasma mem-
brane, where PI(4,5)P2 is responsible for localising other
PH domains [39,40]. This implies either that Golgi-spe-
cific targeting uses a second ligand, or that PIPs are
recognised in a specific context only present on Golgi
membranes. The idea of a second ligand is compatible
with studies showing that PH domains on plasma-mem-
brane-targeted proteins are not always functionally inter-
changeable, despite binding similar PIPs in vitro, and also
that a mutant form of the PH domain from SOS that is
unable to bind PI(4,5)P2 still localises to the plasma
membrane [1,32,43].
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could result from direct binding to a Golgi-specific protein
in combination with PIP. Since OSBP PH binds Golgi
membranes in vitro with approximately micromolar affin-
ity at highly abundant sites, it does not appear that
binding to both protein and lipid occurs in vitro. Never-
theless, such dual recognition might occur in vivo, leading
to binding with higher affinity at a smaller number of
sites. There are a number of examples of proteins binding
directly to PH domains [17]. OSBP PH is one of several
PH domains that have been suggested to bind the β
subunit of heterotrimeric G proteins (Gβ) [44], in particu-
lar interacting with the WD40 repeat regions of Gβ [17].
Gβ binding was examined using only a portion of OSBP
with a 35-residue carboxy-terminal extension beyond the
boundary of the PH domain [15,44], whereas the fusion
proteins used in this study express only the PH domain, as
defined by a consensus with over 70 other sequences [15].
Nevertheless, similar to the PH domain from β-adrenergic
receptor kinase, membrane targeting of OSBP PH could
result from synergistic binding to both PI(4,5)P2 and Gβ at
two distinct binding sites on the PH domain [45]. Alterna-
tively, a Golgi-specific protein could act indirectly in vivo
by modifying the OSBP PH domain, although we found
no evidence for phosphorylation of OSBP PH during in
vitro binding.
As an alternative to a second ligand, targeting may depend
on a Golgi-specific context for the recognition of PI(4,5)P2
that is derived from the unique lipid composition of the
Golgi [34]. For many lipids, the composition of Golgi
membranes is at levels intermediate between those of the
ER and plasma membrane, while some phospholipids are
specifically enriched in the Golgi [34]. It has been shown
previously that the binding affinity of a PH domain to
liposomal PI(4,5)P2 can be modulated up to 10-fold by the
liposomal phospholipid composition, and structural
studies of isolated PH domains have suggested an impor-
tant role for hydrogen bonding between basic residues and
negative phospholipid head-groups [36,46]. Since we have
found that OSBP PH, in comparison with other PH
domains so far described, has not only a high affinity for
PI(4,5)P2 in liposomes and membranes, but also an
extreme (100-fold) preference for PI(4,5)P2 compared to
its head-group, it is possible that OSBP PH binding is
highly dependent on the lipid composition of the bilayer. 
Conclusions
OSBP PH specifically targets to Golgi membranes, recog-
nising a functionally important determinant in a highly
conserved manner. Furthermore, studies of specific mem-
brane binding in vitro suggest that the determinant
includes a PIP, with high-affinity binding directly to
PI(4,5)P2. However, PI(4,5)P2 and closely related PIPs are
found on other organelles, including the plasma mem-
brane. This implies that OSBP PH’s targeting uses a
second, Golgi-specific ligand, or involves recognition of
PIPs in a Golgi-specific context. Our results imply that the
OSBP PH defines a new class of PH domains which co-
recognise a PIP and another determinant, the combination
of both providing specific Golgi targeting. 
Materials and methods
Materials 
Materials were from Sigma, unless otherwise stated. Monoclonal anti-
bodies used were: 23C, anti-β′-COP [19]; 100/3, anti-adaptin [47];
MAC256, anti-KDEL [48]; MAB422, anti-cathepsin D (Chemicon);
9E10, anti-Myc; and 12CA5, anti-HA. TGN46 and syntaxin 5 were
detected with rabbit antisera [20]. 
Cloning PH domains
PH domains were defined as follows: (a) OSBP 87–185 (OSBP PH),
(b) spectrin β1Σ2 2173–2292, (c) ARNO 261–376, (d) PKCµ
421–525, (e) PI4Kα 470–613, (f) PLCδ1 23–135, (g) Osh1p
280–384, (h) Num1p 2571–2687, (i) Stt4p 1529–1649, and (j)
Cdc24p 354–554 [15,18,23,49–51]. All sequences were cloned by
PCR and checked by sequencing: (a) to (e) from human cDNA (Clon-
tech), (f) from a plasmid containing the rat gene [40], and (g) to (j) from
S. cerevisiae genomic DNA. PH domains were cloned with an amino-
terminal extension of GSMEQKLISEEDLRS and a carboxy-terminal
extension of XNS (where X is encoded by the last two nucleotides from
the source DNA and a guanine). Cdc24p had an additional HHHHHH
at the carboxyl terminus.
Plasmid construction
Each PH domain was fused to the carboxyl terminus of a thermostable,
spectrally enhanced GFP [52] that was preceded by a short linker
(MVTSPVEK) and followed by a single residue (L). Fusions were
expressed from plasmid SAGMK1 [53], which has a adenovirus major
late promoter (plasmids pAGP(a–j)), and from SMH5, a plasmid
derived from SAGMK1, with the cytomegalovirus immediate early gene
promoter (plasmids pBGP(a–j)). HA-tagged PH domains had the
sequence MEYPYDVPDYARS, followed by the PH domain. Plasmids
containing His6-tagged PH domains are based on pTrcHisA (Invitro-
gen) coding for MGGSHHHHHH followed by a 24-residue spacer,
then the PH domain. For fluorescent, His6-tagged expressed PH
domains, the amino-terminal 34 residues are the same, followed by
GSTKLP, then the coding sequence from the relevant pAGP plasmid.
Cell transfection and protein localisation
COS or NRK cells were transfected using DEAE–dextran as described
previously [53]. After 4–24 hours, cells were split onto 8-well slides
(C.A. Hendley (Essex) Ltd) and on the following day were treated with
drugs or by temperature shift. Live cells expressing GFP fusions were
examined immediately after mounting under a cover-slip in serum-free
medium. Fixation, permeabilisation, and immunofluorescence using
FITC, Texas red and Cy3 labelled secondary antibodies (Amersham)
were performed as described previously [54]. Images were obtained
on an MRC 600 Confocal microscope. Cryo-electron microscopy with
anti-TGN46 and anti-GFP (gift of Ken Sawin) antibodies was per-
formed as described [55], and sections viewed in a Philips CM10 elec-
tron microscope.
Expression and purification of PH-domain-containing proteins
OSBP PH and PH–GFP fusion proteins, all tagged at the amino termi-
nus with His6, were purified as native cytoplasmic proteins to approxi-
mately 90% purity from Escherichia coli on NTA–agarose (Qiagen), as
described by the manufacturer. For isothermal calorimetry and surface
plasmon resonance, proteins were further fractionated on High Perfor-
mance S resin (Pharmacia) to obtain >95% purity. 
Incubation of PH domains with Golgi membranes
Stacked Golgi membranes were purified from fresh rat livers as
described [56]. Mitochondrial membranes were purified as described
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previously [57]. Incubations were in cytosol buffer (CB; 125 mM potas-
sium acetate, 25 mM HEPES pH 7.4, 5 mM glucose, 2.5 mM magne-
sium chloride and 1 mM DTT) containing 2 mg/ml soybean trypsin
inhibitor, PH–GFP fusion protein (final concentration 6 µg/ml), 5 µl
membranes (final concentration 140 µg/ml). Other additions were as
follows: ATP-regeneration system (8 mM creatine phosphate, 80 µg/ml
creatine kinase type I and 1 mM ATP), or apyrase (5 IU/ml); nonfluores-
cent OSBP PH (de-salted into CB, at concentrations 1–800 µg/ml);
purified GST-tagged PLCδ1 (full length, or with a deletion of residues
1–132, 0.3 mg/ml). For treatment with PLCδ1, membranes were pre-
incubated for 10 min at 37°C with PLCδ1 and EGTA (0.5 mM), either
with 0.5 mM CaCl2 (free Ca2+ 10 µM), or without added calcium (free
calcium <10 nM). After incubation (10 min at 37°C) membranes were
pelleted (11,000 g, 3 min) through a cushion of CB containing 200 mM
sucrose, 1 mM ATP and 0.1 mg/ml hen lysozyme, and the pellets care-
fully rinsed. GFP in pellets and supernatants was quantified in an LS50
Spectrophotometer (Perkin Elmer): excitation 467 nm, emission
509 nm, slits 2.5 nm. Background was defined from assays where GFP
fusions were added to supernatants after pelleting. Alternatively, mem-
brane pellets were resuspended in 50 µl SDS sample buffer, and
probed on protein blots with rabbit anti-GFP (gift of J. Haseloff) and
HRP-conjugated anti-rabbit Ig (Bio-Rad). Blots were reprobed with
rabbit anti-syntaxin 5 antibody (gift of M. Lewis) to confirm recovery of
Golgi membranes.
Isothermal calorimetry
Liposomes containing PIPs (PI(4)P or PI(4,5)P2) and a 19-fold excess
(wt :wt) of DMPC were made up as described [38] except that the
buffer used was 150 mM NaCl, 10 mM HEPES pH 7.5, 2 mM 2-mer-
captoethanol (LB). Calorimetry was performed as described [38]. In
other titrations, IP3 and glycero-PI(4,5)P2 were injected as the ligand
into a solution of OSBP PH.
Surface plasmon resonance
A four-compartment NTA sensor chip was equilibrated in LB contain-
ing 25 µM EDTA (LBE) in a BIAcore 2000™ Biosensor (Pharmacia).
Three His6-tagged proteins were immobilised: OSBP PH, the PH
domain of β1Σ2 spectrin (both fused to GFP), and full-length PLCδ1.
The amount of protein immobilised was proportional to its molecular
weight. Liposomes containing PI(4,5)P2, DMPC and phosphatidylser-
ine in molar ratio 1:20:20 were made as above, diluted in LBE to 1 µM
PI(4,5)P2, resonicated, and injected over the sensor chip for 3 min at
25°C with a constant flow rate of 20 µl/min. The surface was regener-
ated by LBE containing 0.25% TX-100. Competition by IP3 was exam-
ined with the ‘co-inject’ facility: 3 min of 2.5 mM synthetic D-myo-IP3
was directly followed by 3 min of 2.5 mM IP3 and 1 µM PI(4,5)P2,
thereafter returning to LBE.
Acknowledgements
We are indebted to Rose Watson at ICRF Labs, London for assistance with
electron microscopy. We would also like to thank Rob Arkowitz, Howard
Davidson, Jim Haseloff, Mike Lewis, Jennifer Lippincott-Schwartz, Paul
Luzio, Olga Perisic, Vas Ponnambolam, Scottie Robinson and Ken Sawin
for kindly providing reagents, Chris Johnson and Perry Kirkham for technical
advice, and Hugh Pelham, Joost Holthuis, Ben Nichols and Christine
Wiggins for helpful comments on the manuscript. T.P.L. is a Research
Fellow of the British Heart Foundation.
References
1. Kolanus W, Nagel W, Schiller B, Zeitlmann L, Godar S, Stockinger H,
et al.: aLb2 integrin/LFA-1 binding to ICAM-1 induced by
cytohesin-1, a cytoplasmic regulatory molecule. Cell 1996,
86:233-242.
2. Klarlund JK, Guilherme A, Holik JJ, Virbasius JV, Chawla A, Czech MP:
Signaling by phosphoinositide-3,4,5-trisphosphate through
proteins containing pleckstrin and Sec7 homology domains.
Science 1997, 275:1927-1930.
3. Munro S: Localization of proteins to the Golgi apparatus. Trends
Cell Biol 1998, 8:11-15.
4. Taylor FR, Saucier SE, Shown EP, Parish EJ, Kandutsch AA:
Correlation between oxysterol binding to a cytosolic binding
protein and potency in the repression of hydroxymethylglutaryl
coenzyme A reductase. J Biol Chem 1984, 259:2382-2387.
5. Dawson PA, Ridgway ND, Slaughter CA, Brown MS, Goldstein JL:
cDNA cloning and expression of oxysterol-binding protein, an
oligomer with a potential leucine zipper. J Biol Chem 1989,
264:16798-16803.
6. Smith LL: Review of progress in sterol oxidations - 1987-1995.
Lipids 1996, 31:453-487.
7. Johnson KA, Morrow CJ, Knight GD, Scallen TJ: In vivo formation of
25-hydroxycholesterol from endogenous cholesterol after a
single meal, dietary-cholesterol challenge. J Lipid Res 1994,
35:2241-2253.
8. Axelson M, Larsson O: Low-density-lipoprotein (LDL) cholesterol is
converted to 27-hydroxycholesterol in human fibroblasts:
evidence that 27-hydroxycholesterol can be an important
intracellular mediator between LDL and the suppression of
cholesterol production. J Biol Chem 1995, 270:15102-15110.
9. Ridgway N, Dawson P, Ho Y, Brown M, Goldstein J: Translocation of
oxysterol binding protein to Golgi apparatus triggered by ligand
binding. J Cell Biol 1992, 116:307-319.
10. Lagace TA, Byers DM, Cook HW, Ridgway ND: Altered regulation of
cholesterol and cholesteryl ester synthesis in Chinese-hamster
ovary cells overexpressing the oxysterol-binding protein is
dependent on the pleckstrin homology domain. Biochem J 1997,
326:205-213.
11. Ridgway ND, Lagace TA: Brefeldin-A renders Chinese-hamster
ovary cells insensitive to transcriptional suppression by 25-
hydroxycholesterol. J Biol Chem 1995, 270:8023-8031.
12. Harder T, Simons K: Caveolae, DIGs, and the dynamics of
sphingolipid-cholesterol microdomains. Curr Opin Cell Biol 1997,
9:534-542.
13. Ridgway ND: 25-Hydroxycholesterol stimulates sphingomyelin
synthesis in Chinese hamster ovary cells. J Lipid Res 1995,
36:1345-1358.
14. Hua XX, Nohturfft A, Goldstein JL, Brown MS: Sterol resistance in
CHO cells traced to point mutation in SREBP cleavage activating
protein. Cell 1996, 87:415-426.
15. Musacchio A, Gibson T, Rice P, Thompson J, Saraste M: The PH
domain: a common piece in the structural patchwork of signaling
proteins. Trends Biochem Sci 1993, 18:343-348.
16. Saraste M, Hyvonen M: Pleckstrin homology domains - a fact file.
Curr Opin Struct Biol 1995, 5:403-408.
17. Shaw G: The pleckstrin homology domain - an intriguing
multifunctional protein module. Bioessays 1996, 18:35-46.
18. Chardin P, Paris S, Antonny B, Robineau S, Berauddufour S, Jackson
CL, et al.: A human exchange factor for ARF contains Sec7-
homology and pleckstrin-homology domains. Nature 1996,
384:481-484.
19. Harrison-Lavoie KJ, Lewis VA, Hynes GM, Collison KS, Nutland E,
Willison KR: A 102 kda subunit of a Golgi-associated particle has
homology to beta-subunits of trimeric G-proteins. EMBO J 1993,
12:2847-2853.
20. Prescott AR, Lucocq JM, James J, Lister JM, Ponnambalam S: Distinct
compartmentalization of TGN46 and 
b1,4-galactosyltransferase in
HeLa cells. Eur J Cell Biol 1997, 72:238-246.
21. Prestle J, Pfizenmaier K, Brenner J, Johannes F-J: Protein kinase C m
is located at the Golgi compartment. J Cell Biol 1996, 
134:1401-1410.
22. Nakagawa T, Goto K, Kondo H: Cloning, expression, and
localization of 230-kDa phosphatidylinositol 4-kinase. J Biol Chem
1996, 271:12088-12094.
23. Jiang B, Brown JL, Sheraton J, Fortin N, Bussey H: A new family of
yeast genes implicated in ergosterol synthesis is related to the
human oxysterol binding protein. Yeast 1994, 10:341-353.
24. Schmalix WA, Bandlow W: SWH1 from yeast encodes a candidate
nuclear factor-containing ankyrin repeats and showing homology
to mammalian oxysterol-binding protein. Biochim Biophys Acta
1994, 1219:205-210.
25. Donaldson JG, Lippincott-Schwartz J, Bloom GS, Kreis TE, Klausner
RD: Dissociation of a 110-kD peripheral membrane protein from
the Golgi apparatus is an early event in brefeldin A action. J Cell
Biol 1990, 111:2295-2306.
26. Presley JF, Cole NB, Schroer TA, Hirschberg K, Zaal KJ, Lippincott-
Schwartz J: ER-to-Golgi transport visualized in living cells. Nature
1997, 389:81-85.
738 Current Biology, Vol 8 No 13
27. Harlan JE, Hajduk PJ, Yoon HS, Fesik SW: Pleckstrin homology
domains bind to phosphatidylinositol-4,5-bisphosphate. Nature
1994, 371:168-170.
28. Allen V, Swigart P, Cheung R, Cockcroft S, Katan M: Regulation of
inositol lipid-specific phospholipase C
d
by changes in Ca2+ ion
concentrations. Biochem J 1997 327:545-552.
29. Essen LO, Perisic O, Cheung R, Katan M, Williams RL: Crystal-
structure of a mammalian phosphoinositide-specific
phospholipase Cd. Nature 1996, 380:595-602.
30. Rameh LE, Tolias KF, Duckworth BC, Cantley LC: A new pathway for
synthesis of phosphatidylinositol-4,5-bisphosphate. Nature 1997,
390:192-196.
31. Salim K, Bottomley MJ, Querfurth E, Zvelebil MJ, Gout I, Scaife R, et
al.: Distinct specificity in the recognition of phosphoinositides by
the pleckstrin homology domains of dynamin and Brutons
tyrosine kinase. EMBO J 1996, 15:6241-6250.
32. Chen RH, CorbalanGarcia S, BarSagi D: The role of the PH domain
in the signal-dependent membrane targeting of Sos. EMBO J
1997, 16:1351-1359.
33. Warren GB, Toon PA, Birdsall NJM, Lee AG, Metcalfe JC:
Reconstitution of a calcium pump using defined membrane
components. Proc Natl Acad Sci USA 1974, 71:622-626.
34. Cluett EB, Kuismanen E, Machamer CE: Heterogeneous distribution
of the unusual phospholipid semilysobisphosphatidic acid
through the Golgi complex. Mol Biol Cell 1997, 8:2233-2240.
35. Bunce CM, French PJ, Allen P, Mountford JC, Moor B, Greaves MF, et
al.: Comparison of the levels of inositol metabolites in
transformed hematopoietic-cells and their normal counterparts.
Biochem J 1993, 289:667-673.
36. Garcia P, Gupta R, Shah S, Morris AJ, Rudge SA, Scarlata S, et al.:
The pleckstrin homology domain of phospholipase C d1 binds
with high affinity to phosphatidylinositol 4,5- bisphosphate in
bilayer membranes. Biochemistry 1995, 34:16228-16234.
37. Kubiseski TJ, Chook YM, Parris WE, Rozakis-Adcock M, Pawson T:
High affinity binding of the pleckstrin homology domain of mSos1
to phosphatidylinositol (4,5)-bisphosphate. J Biol Chem 1997,
272:1799-1804.
38. Lemmon MA, Ferguson KM, O’Brien R, Sigler PB, Schlessinger J:
Specific and high-affinity binding of inositol phosphates to an
isolated pleckstrin homology domain. Proc Natl Acad Sci USA
1995, 92:10472-10476.
39. Lemmon MA, Falasca M, Ferguson KM, Schlessinger J: Regulatory
recruitment of signalling molecules to the cell membrane by
pleckstrin-homology domains. Trends Cell Biol 1997, 7:237-242.
40. Paterson HF, Savopoulos JW, Perisic O, Cheung R, Ellis MV, Williams
RL, et al.: Phospholipase C d 1 requires a pleckstrin homology
domain for interaction with the plasma membrane. Biochem J
1995, 312:661-666.
41. Rameh LE, Arvidsson AK, Carraway KL, Couvillon AD, Rathbun G,
Crompton A, et al.: A comparative analysis of the phosphoinositide
binding specificity of pleckstrin homology domains. J Biol Chem
1997, 272:22059-22066.
42. Domin J, Pages F, Volinia S, Rittenhouse SE, Zvelebil MJ, Stein RC, et
al.: Cloning of a human phosphoinositide 3-kinase with a C2
domain that displays reduced sensitivity to the inhibitor
wortmannin. Biochem J 1997, 326:139-147.
43. Burks DJ, Pons S, Towery H, Smith-Hall J, Myers M, Yenush L, et al.:
Heterologous pleckstrin homology domains do not couple IRS-1
to the insulin receptor. J Biol Chem 1997, 272:27716-27721.
44. Touhara K, Inglese J, Pitcher JA, Shaw G, Lefkowitz RJ: Binding of G-
protein bg-subunits to pleckstrin homology domains. J Biol Chem
1994, 269:10217-10220.
45. Pitcher JA, Touhara K, Payne ES, Lefkowitz RJ: Pleckstrin homology
domain-mediated membrane association and activation of the
beta-adrenergic-receptor kinase requires coordinate interaction
with G(bg) subunits and lipid. J Biol Chem 1995, 
270:11707-11710.
46. Hyvonen M, Macias MJ, Nilges M, Oschkinat H, Saraste M, Wilmanns
M: Structure of the binding-site for inositol phosphates in a PH
domain. EMBO J 1995, 14:4676-4685.
47. Ahle S, Mann A, Eichelsbacher U, Ungewickell E: Structural
relationships between clthrin assembly proteins from the Golgi
and the plasma-membrane. EMBO J 1988, 7:919-929.
48. Napier RM, Fowke LC, Hawes C, Lewis M, Pelham HRB:
Immunological evidence that plants use both HDEL and KDEL for
targeting proteins to the endoplasmic-reticulum. J Cell Sci 1992,
102:261-271.
49. Wong K, Cantley LC: Cloning and characterization of a human
phosphatidylinositol 4-kinase. J Biol Chem 1994, 
269:28878-28884.
50. Ferguson KM, Lemmon MA, Schlessinger J, Sigler PB: Structure of
the high-affinity complex of inositol trisphosphate with a
phospholipase C pleckstrin homology domain. Cell 1995,
83:1037-1046.
51. Yoshida S, Goebl M, Ohya Y, Nakano A, Anraku Y: A novel gene,
STT4, encodes a phosphatidylinositol 4-kinase in the PKC1
protein kinase pathway of Saccharomyces cerevisiae. J Biol Chem
1994, 269:1166-1172.
52. Siemering KR, Golbik R, Sever R, Haseloff J: Mutations that
suppress the thermosensitivity of green fluorescent protein. Curr
Biol 1996, 6:1653-1663.
53. Munro S, Pelham HRB: A C-terminal signal prevents secretion of
luminal ER proteins. Cell 1987, 48:899-907.
54. Munro S: An investigation of the role of transmembrane domains
in Golgi protein retention. EMBO J 1995, 14:4695-4704.
55. Rabouille C, Hui N, Hunte F, Kieckbusch R, Berger EG, Warren G:
Mapping the distribution of Golgi enzymes involved in the
construction of complex oligosaccharides. J Cell Sci 1995,
108:1617-1627.
56. Slusarewicz P, Hui N, Warren G: Purification of rat liver Golgi
stacks In Cell Biology: a Laboratory Handbook Vol. 1. Edited by
Celis JE. Orlando, Florida: Academic Press; 1994:509-516.
57. Levine TP, Rabouille C, Kieckbusch RH, Warren G: Binding of the
vesicle docking protein p115 to Golgi membranes is inhibited
under mitotic conditions. J Biol Chem 1996, 271:17304-17311.
Research Paper  A PH domain targeted to the Golgi Levine and Munro    739
Because Current Biology operates a ‘Continuous Publication
System’ for Research Papers, this paper has been published
on the internet before being printed. The paper can be
accessed from http://biomednet.com/cbiology/cub — for
further information, see the explanation on the contents page.
